Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2005
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/26/2005CN1688558A Thiazolyl biphenyl amides
10/26/2005CN1688557A Thiazole compounds for treatment of neurodegenerative disorders
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1687040A Method for extracting 2-mercapto benzothiazole
10/25/2005US6958401 Method for synthesizing epothilones and epothilone analogs
10/25/2005US6958355 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097787A2 Novel benzothiazoles and the use thereof as medicaments
10/20/2005WO2005097784A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005WO2005097767A1 2-aminothiazole compounds useful as aspartyl protease inhibitors
10/20/2005WO2005097766A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
10/20/2005WO2005097765A1 Anaplastic lymphoma kinase modulators and methods of use
10/20/2005WO2005097764A1 Thiazole derivative
10/20/2005WO2005097114A2 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
10/20/2005WO2005097100A2 Antibacterial agents
10/20/2005WO2005096734A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005WO2005084205A3 Diamino thiazoloindan derivatives and their use
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050234020 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
10/20/2005CA2562140A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005CA2561945A1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005CA2561928A1 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
10/20/2005CA2561267A1 2-aminothiazole compounds useful as aspartyl protease inhibitors
10/20/2005CA2561249A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
10/20/2005CA2560683A1 Novel benzothiazoles and the use thereof as medicaments
10/20/2005CA2559866A1 Anaplastic lymphoma kinase modulators and methods of use
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1586556A2 Compounds to treat Alzheimer's disease
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585739A1 Substituted arylcyclopropylacetamides as glucokinase activators
10/19/2005EP1585726A1 Fused heterocyclic derivatives as ppar modulators
10/19/2005EP1585541A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
10/19/2005EP1585518A2 Peptide deformylase inhibitors
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1414446B1 Pramipexol as an anticonvulsive agent
10/19/2005EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1683370A Hetaryl-substd. heterocycles
10/19/2005CN1683348A Aminobenzothiazole monomer containing alicyclic macro side group and its preparing method
10/19/2005CN1683347A Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use
10/19/2005CN1223588C Process for preparing alcohol by heterocyclic carboxylic ester
10/18/2005US6956049 Methods of modulating processes mediated by excitatory amino acid receptors
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955744 Purifying 2-chloro-5-chloromethyl-thiazole, characterized in that crude material of the compound is distilled under reduced pressure in the presence of a polyether
10/13/2005WO2005095367A1 Thiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005061458A3 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
10/13/2005WO2005035489A8 Improved synthesis of discodermolide and variants thereof
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050228031 Tyrosine kinase inhibitors
10/13/2005US20050228021 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
10/13/2005US20050228017 Novel anticancer compounds
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050226926 Sustained-release tablet composition of pramipexole
10/13/2005DE10392134T5 Azaphenylalaninderivate Azaphenylalaninderivate
10/13/2005DE102004013528A1 New aza-heterocyclic spiro-cyclopropyl compounds, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2562123A1 Thiazole-amine compounds for the treatment of neurodegenerative disorders
10/12/2005EP1583760A2 Substituted heterocyclic compounds
10/12/2005EP1583752A2 Cyclization process for substituted benzothiazole derivatives
10/12/2005EP1583751A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases
10/12/2005EP1583530A1 2-aminothiazole allosteric enhancers of a1-adenosine receptors
10/12/2005EP1583529A2 Amino acid phenoxy ethers
10/12/2005EP1194421B1 Selective npy (y5) antagonists
10/12/2005EP0977563B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1222524C Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2, 4-dione maleate and process for their preparation
10/12/2005CN1222501C Novel compounds
10/12/2005CN1222374C Extrusion die
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953795 N-[5-[[3[-(morpholin-4-yl)carbonyl]phenyl]thio]thiazol-2-yl]-4-(N,N-dimethylamino)benzamide; may be combined with antiinflammatory, antiarthritic, antiproliferative, anticancer, anti-cytotoxic or antiallergenic agents
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092871A2 Intermediates for the preparation of pramipexole
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 337